Our analytical methods are designed to intelligently link microbiome components to clinical pathways, identifying crucial elements for predicting T2D risk.
Deepbiomics
Multi-Omics AI Analysis for Precision Healthcare
DeepBiomics integrates and analyses multi-omics data through advanced deep learning. Our algorithms handle complex, high-dimensional biological datasets spanning genomics, transcriptomics, proteomics, and clinical phenotypes, delivering precision insights that drive better healthcare decisions. Whether you are running a clinical trial, evaluating a dietary intervention, or exploring disease biomarkers, DeepBiomics helps you extract meaningful patterns from noisy, high-dimensional data.
How does Deepbiomics work?
Innovative graph and network-based representation
Our advanced graph and network-based models distill complex biological processes into clear, interpretable representations. By decomposing proteins, gene sequences, and molecular pathways into structured components, DeepBiomics delivers rapid, accurate personalised insights for biological research and precision healthcare.
Tailored Algorithms for a Holistic Understanding of Biological Systems
The Deepbiomics Platform functions as a powerful computational engine, rapidly evaluating complex biological data to deliver tailored healthcare insights. Our advanced algorithms work with a wide range of data technologies, such as gene ontology, route databases, metagenomics, proteomics, epigenetics, 3D structural data of proteins, cellular imaging, and large text corpora.
Increasing Intricacy while Maintaining Nuance
Our network and graph models capture the complex intricacies of biological systems, and ensure the precise delivery of personalized data. This commitment aligns with our mission to accelerate insights and drive innovative healthcare solutions.
Explore our research areas
Type 2 Diabetes with AI and Microbiome Data
Cardiovascular Risk Prediction Through Advanced Proteomics
Our models excel at identifying a constellation of key biomarkers, significantly enhancing the prediction of cardiovascular events.
Epigenetics and inflammatory bowel disease
Traditional treatment approaches often rely on a trial-and-error method due to the lack of reliable biomarkers to predict treatment outcomes.
